Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis Journal Article

   

Authors:	Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Lacouture, M. E.; Hajdenberg, J.; Ganzel, C.; Diamond, E. L.
Article Title:	Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis
Keywords:	adult; clinical article; aged; fatigue; drug withdrawal; cytarabine; nuclear magnetic resonance imaging; technetium 99m; skin defect; cell infiltration; bone pain; retrospective study; arthralgia; dizziness; dyspnea; toxicity; b raf kinase; hearing impairment; bone scintiscanning; cd68 antigen; metastatic melanoma; langerhans cell histiocytosis; hypertransaminasemia; dysarthria; vemurafenib; dabrafenib; t6 antigen; human; male; female; article; erdheim chester disease; positron emission tomography-computed tomography
Journal Title:	Haematologica
Volume:	103
Issue:	4
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2018-04-01
Start Page:	e177
End Page:	e180
Language:	English
DOI:	10.3324/haematol.2017.185298
PROVIDER:	scopus
PMCID:	PMC5865413
PUBMED:	29472347
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044422869&doi=10.3324%2fhaematol.2017.185298&partnerID=40&md5=1512bfc751bef6f8f87faa3e4e63cb4d
Notes:	Article -- Export Date: 1 May 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/122923